Validation study of genetic associations with coronary artery disease on chromosome 3q13-21 and potential effect modification by smoking

Annals of Human Genetics

Volumn 73, Issue 6, 2009, Pages 551-558

  Horne, Benjamin D ^a,b   Hauser, Elizabeth R ^c   Wang, Liyong ^d   Muhlestein, Joseph B ^a,b   Anderson, Jeffrey L ^a,b   Carlquist, John F ^a,b   Shah, Svati H ^c   Kraus, William E ^c  

^a INTERMOUNTAIN MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary disease; Genetic association; Replication study; Smoking

Indexed keywords

BINDING PROTEIN; KALIRIN; MYOSIN LIGHT CHAIN KINASE; PROTEIN CDC42; TRANSCRIPTION FACTOR GATA 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHROMOSOME 3Q; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; VALIDATION STUDY;

AGE OF ONSET; AGED; CHROMOSOMES, HUMAN, PAIR 3; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING;

EID: 70350537083     PISSN: 00034800     EISSN: 14691809     Source Type: Journal    
DOI: 10.1111/j.1469-1809.2009.00540.x     Document Type: Article

References (21)

1. Bowden D W, Rudock M, Ziegler J, Lehtinen A B, Xu J, Wagenknecht L E, Herrington D, Rich S S, Freedman B I, Carr J J, Langefeld C D. Coincident linkage of type 2 diabetes, metabolic syndrome, and measures of cardiovascular disease in a genome scan of the diabetes heart study. Diabetes 2006, 55:1985-1994.
2. Cernuda-Morollon E, Ridley A J. Rho GTPases and leukocyte adhesion receptor expression and function in endothelial cells. Circ Res 2006, 98:757-767.
3. Connelly J J, Wang T, Cox J E, Haynes C, Wang L, Shah S H, Crosslin D R, Hale A B, Nelson S, Crossman D C, Granger C B, Haines J L, Jones C J, Vance J M, Goldschmidt-Clermont P J, Kraus W E, Hauser E R, Gregory S G. GATA2 is associated with familial early-onset coronary artery disease. PLoS Genet 2006, 2:e139.
4. Cooke J P, Losordo D W. Nitric oxide and angiogenesis. Circulation 2002, 105:2133-2135.
5. Freeman D J, Samani N J, Wilson V, McMahon A D, Braund P S, Cheng S, Caslake M J, Packard C J, Gaffney D. A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study. Eur Heart J 2003, 24:1833-1842.
6. Hauser E R, Crossman D C, Granger C B, Haines J L, Jones C J, Mooser V, McAdam B, Winkelmann B R, Wiseman A H, Muhlestein J B, Bartel A G, Dennis C A, Dowdy E, Estabrooks S, Eggleston K, Francis S, Roche K, Clevenger P W, Huang L, Pedersen B, Shah S, Schmidt S, Haynes C, West S, Asper D, Booze M, Sharma S, Sundseth S, Middleton L, Roses A D, Hauser M A, Vance J M, Pericak-Vance M A, Kraus W E. A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am J Hum Genet 2004, 75:436-447.
7. Hegele R A. SNP judgments and freedom of association. Arterioscler Thromb Vasc Biol 2002, 22:1058-1061.
8. Horne B D, Camp N J, Anderson J L, Mower C P, Kolek M J, Clarke J L, Carlquist J F. Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery disease. J Am Coll Cardiol 2007, 49:2053-2060.
9. Ioannidis J P, Ntzani E E, Trikalinos T A, Contopoulos-Ioannidis D G. Replication validity of genetic association studies. Nat Genet 2001, 29:306-309.
10. Knaus U G. Rho GTPase signaling in inflammation and transformation. Immunol Res 2000, 21:103-109.
11. Luo A K, Jefferson B K, Garcia M J, Ginsburg G S, Topol E J. Challenges in the phenotypic characterisation of patients in genetic studies of coronary artery disease. J Med Genet 2007, 44:161-165.
12. Ratovitski E A, Bao C, Quick R A, McMillan A, Kozlovsky C, Lowenstein C J. An inducible nitric-oxide synthase (NOS)-associated protein inhibits NOS dimerization and activity. J Biol Chem 1999, 274:30250-30257.
13. Ren J, Fang C X. Small guanine nucleotide-binding protein Rho and myocardial function. Acta Pharmacol Sin 2005, 26:279-285.
14. Sen-Banerjee S, Siles X, Campos H. Tobacco smoking modifies association between Gln-Arg192 polymorphism of human paraoxonase gene and risk of myocardial infarction. Arterioscler Thromb Vasc Biol 2000, 20:2120-2126.
15. Shimokawa H, Takeshita A. Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol 2005, 25:1767-1775.
16. Smith L R, Harrell F E, Rankin J S, Califf R M, Pryor D B, Muhlbaier L H, Lee K L, Mark D B, Jones R H, Oldham H N. Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. Circulation 1991, 84(suppl 5):III245-III253.
17. Talmud P J, Bujac S R, Hall S, Miller G J, Humphries S E. Substitution of asparagines for aspartic acid at residue 9 (D9N) of lipoprotein lipase markedly augments risk of ischaemic heart disease in male smokers. Atherosclerosis 2000, 149:75-81.
18. Talmud P J, Stephens J W, Hawe E, Demissie S, Cupples L A, Hurel S J, Humphries S E, Ordovas J M. The significant increase in cardiovascular disease risk in APOE e{open}4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4. Ann Hum Genet 2005, 69:613-622.
19. Talmud P J. Gene-environment interaction and its impact on coronary heart disease risk. Nutr Metab Cardiovasc Dis 2007, 17:148-152.
20. Taylor G S, Muhlestein J B, Wagner G S, Bair T L, Li P, Anderson J L. Implementation of a computerized cardiovascular information system in a private hospital setting. Am Heart J 1998, 136:792-803.
21. Wang L, Hauser E R, Shah S H, Pericak-Vance M A, Haynes C, Crosslin D, Harris M, Nelson S, Hale A B, Granger C B, Haines J L, Jones C J H, Crossman D, Seo D, Gregory S G, Kraus W E, Goldschmidt-Clermont P J, Vance J M. Peakwide mapping on chromosome 3q13 identifies the Kalirin gene as a novel candidate gene for coronary artery disease. Am J Hum Genet 2007, 80:650-663.